MLAB Mesa Laboratories Inc

  1. Stocks
  2. Technology
  3. NASDAQ: MLAB

Price (delayed)

$106.04

Market cap

$593.39M

P/E Ratio

123.3

Dividend/share

$0.64

EPS

$0.86

Enterprise value

$721.41M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 72

Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. ...

Highlights
The company's quick ratio has surged by 185% YoY
The debt has contracted by 12% YoY and by 3.9% from the previous quarter
The company's EPS fell by 30% QoQ
Mesa Laboratories's net income has decreased by 28% QoQ
Sector: Technology
Industry: Scientific & Technical Instruments
Website: http://www.mesalabs.com
Peers: TMO HBIO AME STE

Key stats

What are the main financial stats of MLAB

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
-6.33%
1 week
3.3%
1 month
12.05%
1 year
56.19%
YTD
35.08%
QTD
6.52%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$249.73M
Gross profit
$160.34M
Operating income
$22.48M
Net income
$4.8M
Gross margin
64.2%
Net margin
1.9%
MLAB's operating income has soared by 63% YoY and by 21% from the previous quarter
The operating margin has soared by 58% YoY and by 22% from the previous quarter
The net margin has contracted by 30% from the previous quarter
Mesa Laboratories's net income has decreased by 28% QoQ

Price vs fundamentals

How does MLAB's price correlate with its fundamentals

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
MLAB P/E details
P/E
123.3
P/B
3.1
P/S
2.4
EV/EBIT
35.69
EV/EBITDA
16.71
EV/Sales
2.89
The company's EPS fell by 30% QoQ
MLAB's price to book (P/B) is 24% more than its last 4 quarters average of 2.5 and 7% more than its 5-year quarterly average of 2.9
MLAB's equity is up by 9% year-on-year
The P/S is 38% below the 5-year quarterly average of 3.9 but 26% above the last 4 quarters average of 1.9
MLAB's revenue is up by 3% year-on-year

Efficiency

How efficient is Mesa Laboratories business performance
The return on assets has declined by 31% since the previous quarter
MLAB's return on equity is down by 30% since the previous quarter
Mesa Laboratories's return on invested capital has decreased by 29% YoY and by 17% QoQ
The company's return on sales fell by 11% QoQ

Dividends

What is MLAB's dividend history
Dividend details
DPS
$0.64
Dividend yield
0.6%
Payout ratio
74.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 82% more than its total liabilities
The company's quick ratio has surged by 185% YoY
MLAB's current ratio has surged by 171% year-on-year and by 4.1% since the previous quarter
The debt is 16% less than the equity
MLAB's debt to equity is down by 20% YoY and by 6% QoQ
The debt has contracted by 12% YoY and by 3.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.